Search
for
Sort by
Research 31–60 of 1000+
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Supplementary file 1_Research progress in the treatment of non-scarring alopecia: mechanism and treatment.docx
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- A review of Janus kinase inhibitor use in scarring alopecia
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Treatment of Lichen Planopilaris With Abrocitinib
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Modern dermatology brings treatment even for alopecia areata
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- New drugs under investigation for the treatment of alopecias
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Emerging role of baricitinib in dermatology practice: All we need to know!